Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor and Scientific Conferences in March N...
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...